Advertisement
COMMUNICATION| Volume 274, ISSUE 16, P10693-10696, April 16, 1999

Trimethylamine N-Oxide-induced Cooperative Folding of an Intrinsically Unfolded Transcription-activating Fragment of Human Glucocorticoid Receptor*

  • Ilia V. Baskakov
    Affiliations
    From the Department of Human Biological Chemistry and Genetics, University of Texas Medical Branch, Galveston, Texas 77555-0645
    Search for articles by this author
  • Raj Kumar
    Affiliations
    From the Department of Human Biological Chemistry and Genetics, University of Texas Medical Branch, Galveston, Texas 77555-0645
    Search for articles by this author
  • Ganesan Srinivasan
    Affiliations
    From the Department of Human Biological Chemistry and Genetics, University of Texas Medical Branch, Galveston, Texas 77555-0645
    Search for articles by this author
  • Yan-shan Ji
    Affiliations
    From the Department of Human Biological Chemistry and Genetics, University of Texas Medical Branch, Galveston, Texas 77555-0645
    Search for articles by this author
  • D. Wayne Bolen
    Affiliations
    From the Department of Human Biological Chemistry and Genetics, University of Texas Medical Branch, Galveston, Texas 77555-0645
    Search for articles by this author
  • E. Brad Thompson
    Correspondence
    To whom correspondence should be addressed: Dept. of Human Biological Chemistry and Genetics, University of Texas Medical Branch, 301 University Blvd., 605 Basic Science Bldg., Galveston, TX 77555-0645. Tel.: 409-772-2271; Fax: 409-772-5159;
    Affiliations
    From the Department of Human Biological Chemistry and Genetics, University of Texas Medical Branch, Galveston, Texas 77555-0645
    Search for articles by this author
  • Author Footnotes
    * This work was supported by NCI Grant CA41407 (to E. B. T.) and NIGMS Grant GM 49760 (to D. W. B.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Open AccessPublished:April 16, 1999DOI:https://doi.org/10.1074/jbc.274.16.10693
      A number of biologically important proteins or protein domains identified recently are fully or partially unstructured (unfolded). Methods that allow studies of the propensity of such proteins to fold naturally are valuable. The traditional biophysical approaches using alcohols to drive α-helix formation raise serious questions of the relevance of alcohol-induced structure to the biologically important conformations. Recently we illustrated the extraordinary capability of the naturally occurring solute, trimethylamine N-oxide (TMAO), to force two unfolded proteins to fold to native-like species with significant functional activity. In the present work we apply this technique to recombinant human glucocorticoid receptor fragments consisting of residues 1–500 and residues 77–262. CD and fluorescence spectroscopy showed that both were largely disordered in aqueous solution. TMAO induced a condensed structure in the large fragment, indicated by the substantial enhancement in intrinsic fluorescence and blue shift of fluorescent maxima. CD spectroscopy demonstrated that the TMAO-induced structure is different from the α-helix-rich conformation driven by trifluoroethanol (TFE). In contrast to TFE, the conformational transition of the 1–500 fragment induced by TMAO is cooperative, a condition characteristic of proteins with unique structures.
      An increasing number of biologically important proteins and protein domains have been found to be only partially structured or unstructured (unfolded) under physiological conditions (
      • Weinreb P.H.
      • Zhen W.
      • Poon A.W.
      • Conway K.A.
      • Lansbury P.T.
      ). Notably, many of the nuclear transcription factors show disordered transactivation domains in aqueous solution (). It is generally accepted that the structural uniqueness of proteins determines their biological function. Hence, the identification of unstructured proteins raises the question: what is the structural basis of the functional activity of such proteins/domains? Whether they act being in unfolded state (“natively unfolded” proteins) or adopt structure upon specific interaction with target molecules is a crucial question. The induced-fit and acidic blob models of the function for such transcription factor proteins represent two opposite points of view (
      • Frankel A.D.
      • Kim P.S.
      ). Hence, methods that allow studies of the propensity of proteins to fold naturally are valuable.
      Alcohols (trifluoroethanol, chloroethanol) have long been used to probe the propensity of unstructured protein/domain to form secondary structure (
      • Dahlman-Wright K.
      • Baumann H.
      • McEwan I.J.
      • Almlof T.
      • Wright A.P.H.
      • Gustafsson J.-A.
      • Hard T.
      ,
      • Schmitz M.L.
      • Silva M.A.S.
      • Altmann H.
      • Czisch M.
      • Holak T.A.
      • Baeuerle P.A.
      ,
      • Donaldson L.
      • Capone J.P.
      ). Their use has in part been based on the assumption that alcohols might mimic the in vivo conditions under which the disordered domain interacts with a target molecule. It has long been known, however, that alcohols favor the α-helical conformation in peptides or proteins regardless of the type of the secondary structure the proteins/peptides form in the biologically relevant (native) conformation (
      • Buck M.
      • Schwalbe H.
      • Dobson C.M.
      ,
      • Fan P.
      • Bracken C.
      • Baum J.
      ,
      • Sönnichsen F.D.
      • Van Eyk J.E.
      • Hodges R.S.
      • Sykes B.D.
      ). Hence, until interacting partners of unstructured domains are identified, the current biophysical approaches using such alcohols to drive α-helix formation present serious difficulties in interpreting results in the context of biology.
      Recently we demonstrated the extraordinary ability of a naturally occurring solute, trimethylamine N-oxide (TMAO),
      The abbreviations used are: TMAO, trimethylamineN-oxide; TFE, trifluoroethanol; hGR, human glucocorticoid receptor; DBD, DNA-binding domain; GR 1–500, recombinant hGR fragment containing residues 1–500; AF1, recombinant hGR transactivation domain 1 containing residues 77–262; AAD, acidic transactivation domain.
      1The abbreviations used are: TMAO, trimethylamineN-oxide; TFE, trifluoroethanol; hGR, human glucocorticoid receptor; DBD, DNA-binding domain; GR 1–500, recombinant hGR fragment containing residues 1–500; AF1, recombinant hGR transactivation domain 1 containing residues 77–262; AAD, acidic transactivation domain.
      to force thermodynamically unstable proteins to fold (
      • Baskakov I.V.
      • Bolen D.W.
      ). Based on the two examples studied, we have shown that TMAO can increase the population of native state relative to denatured state by several orders of magnitude. These proteins regained high functional activity in the presence of TMAO. The present work addresses the question of whether TMAO can induce an unstructured region of transcription factor for which ordered conformation has never been identified to adopt a unique structure.
      We studied large fragments of recombinant human glucocorticoid receptor (hGR, Fig. 1), the protein that mediates the action of glucocorticoids, hormones essential for human life. The hGR is a required intermediate in the physiological and many of pharmacological actions of the glucocorticoids, compounds often used for the treatment of lymphomas and leukemias and to inhibit the immune response. The hGR has a complex modular structure consisting of several domains: steroid-binding, DNA-binding, and two activation function domains (AF1 and AF2), which are acidic regions responsible for GR's post-DNA-binding transactivation potential (). The DNA-binding domains have defined secondary and tertiary structure (
      • Hard T.
      • Kellenbach E.
      • Boelens R.
      • Maler B.A.
      • Dahlman K.
      • Freedman L.P.
      • Carlstedt-Duke J.
      • Yamamoto K.R.
      • Gustafsson J.-A.
      • Kaptein R.
      ,
      • Luisi B.F.
      • Xu W.X.
      • Otwinowski Z.
      • Freedman L.P.
      • Yamamoto K.R.
      • Sigler P.B.
      ), and by analogy with those of other steroid receptors, so does the steroid-binding domain (
      • Wurtz J.-M.
      • Borguet W.
      • Renaud J.-P.
      • Vivat V.
      • Chambon P.
      • Moras D.
      • Gronemeyer H.
      ). The isolated AF1 has been found to be unstructured in aqueous solution (
      • Dahlman-Wright K.
      • Baumann H.
      • McEwan I.J.
      • Almlof T.
      • Wright A.P.H.
      • Gustafsson J.-A.
      • Hard T.
      ). Here, we show that TMAO cooperatively induces structure in the hGR 1–500 fragment (GR 1–500) and that the TMAO-induced structure is different from the α-helix-rich conformation driven by TFE. In the smaller AF1 fragment (residues 77–262) both TMAO and TFE induced similar structures.
      Figure thumbnail gr1
      Figure 1Diagram of human GR 1–500 with AF1 and DBD domains highlighted. All Trp (bold vertical lines) and Tyr (thin vertical lines) residues are shown.

      EXPERIMENTAL PROCEDURES

      Solutions of TMAO (Sigma) were prepared as described by Baskakov and Bolen (
      • Baskakov I.V.
      • Bolen D.W.
      ).
      Construction and expression of GR 1–500 has been described (
      • Chen H.
      • Srinivasan G.
      • Thompson E.B.
      ,
      • Graham F.L.
      • Van der Eb A.J.
      ). The expression vector contained a frameshift mutant of hGR coding for amino acids 1–500 plus codons for a unique 5-amino acid sequence followed by a stop codon. Cytosolic fractions were prepared from the cell pellet (
      • Srinivasan G.
      • Thompson E.B.
      ). The AF1 domain fragment was extracted from hGR cDNA digested with BglII and inserted into an expression vector pGEX-4T-1 (Amersham Pharmacia Biotech). The recombinant expression plasmid pGEX-4T/AF1 was selected and transformed intoEschericha coli BL21. The bacteria containing the recombinant vector for GST-AF1 were induced with isopropyl-β-d-thiogalactopyranoside (0.5 mm) for 3 h, lysed, and extracted. Insect cell cytosol containing the expressed protein (GST-GR 1–500) or bacterial extracts containing (GST-AF1) were loaded onto a glutathione-Sepharose column at 4 °C. After thorough washing of column, the GST-GR 1–500 or GST-AF1 bound to the resin was incubated with alkaline phosphatase for 30 min at room temperature to dephosphorylate the peptide. The hGR fragments were then cleaved from GST by digesting with thrombin at 4 °C for 4 h, collected, and concentrated using Amicon Centriprep units. Protein purity was analyzed by SDS-polyacrylamide gel electrophoresis stained with Coomassie Blue R-250 and estimated to be greater than 90%.
      Fluorescence spectra of GR 1–500 in solution (30 μg/ml, 10 mm Tris, 10 mm NaCl, 10 mmdithiothreitol, pH 7.9) were monitored using a Spex Fluoro Max spectrofluorimeter (excitation 278 or 295 nm). All measurements were made using 1-cm rectangular cuvettes thermostatted at 22 °C, and all data were corrected for the contribution of the respective solute concentrations.
      CD spectra were recorded using a Olis RSM CD Spectrometer at variable scan rate (always slower than 60 nm/min) in 0.1-cm cuvettes thermostatted at 22 °C in 10 mm Tris, 10 mmNaCl buffer, pH 7.9. The bandwidth was 1 nm with data spacing 0.5 nm, and each spectrum shown is the result of 10–20 spectra accumulated, averaged and smoothed. All spectra were corrected for the contributions of the respective buffers.

      RESULTS

      TMAO Forces the GR 1–500 Fragment to Fold in a Cooperative Manner

      Fig. 1 diagrams the regions of the hGR studied, with the location of the Tyr and Trp residues therein. Fig. 2 presents the fluorescence emission spectra of GR 1–500 measured either upon excitation at 295 nm, to follow changes in the environment of Trp residues specifically, or upon excitation at 278 nm, in which emission arises from Tyr and Trp residues as well as being a result of energy transfer from Tyr to Trp residues. Thus, the latter protocol links Tyr probes distributed throughout the protein (Fig. 1) with fluorescence emission from the two Trp residues. Because a substantial fraction of the fluorescence probes of GR 1–500 is located outside of the DBD sequence (both Trp residues, Trp213 and Trp365, and 7 out of 10 Tyr residues, Fig. 1), the intrinsic fluorescence reflects mainly changes involving the AF1 and adjacent regions. The quantum yield of the emission spectra obtained in aqueous solution and in a strongly denaturant conditions (7 m guanidine HCl) are similar, illustrating that the extra DBD portion of GR 1–500 is largely unfolded in this low-salt buffer solution. GR 1–500 aggregates if in ≥0.1 m NaCl. However, the emission spectra change dramatically upon addition of TMAO. There is a 2.5-fold increase in quantum yield and a shift in emission maximum from 350 nm in the absence of TMAO to 331 nm in the presence of 3.5 m TMAO. The fluorescence changes are typical of those accompanying the removal of aromatic residues from polar aqueous solution into a more hydrophobic environment. Both the increase in quantum yield and the blue shift in fluorescence maximum indicate the formation of compact structure in the presence of TMAO. TMAO induces the conformational transition in GR 1–500 in a cooperative manner, as shown by monitoring the level of fluorescence at 329 nm (upon excitation at 278 and 295 nm) and the shift in emission maximum, as a function of TMAO concentration (Fig. 2 C).
      Figure thumbnail gr2
      Figure 2Fluorescence emission spectra (A, 295 nm excitation; B, 278 nm excitation) of GR 1–500 in the absence of solutes (thin solid lines), in 7 mguanidine HCl (bold solid lines), and in the presence of 1.2, 1.9, 2.8, and 3.8 m TMAO (dashed lines, from bottom to top). C, reversible TMAO-induced conformational transition of 1–500 fragment monitored at 329 nm emission with excitation at 278 nm (open square) or excitation at 295 nm (open circle) or monitored by change in emission maxima (1000/λmax, filled diamond) upon excitation at 278 nm. The nonlinear least squares best fit of experimental data to the two-state model of protein folding/denaturation using linear extrapolation methods (thin curve) (
      • Santoro M.M.
      • Bolen D.W.
      ) gives apparent thermodynamic parameters of TMAO-induced folding: ΔG = −2.4 ± 0.9 kcal/mol, m = 1.9 ± 0.6 kcal/mol. All measurements (in A–C) were performed in 10 mm Tris, 10 mm NaCl, 10 mm dithiothreitol, pH 7.9 at 12 °C with concentration of protein 0.56 μm. To prevent aggregation of protein we used proline at a constant molar ratio of TMAO:proline as 4:1 in all samples containing TMAO.

      GR 1–500 Adopts Different Secondary Structure in TMAO and TFE Solutions

      GR 1–500 in the absence of solute shows considerable unfolded secondary structure in aqueous solution as measured by CD (Fig. 3 A). It is reasonable to believe that the small amount of secondary structure observed is due to DBD, which is known to be an independently folding domain (
      • Hard T.
      • Kellenbach E.
      • Boelens R.
      • Maler B.A.
      • Dahlman K.
      • Freedman L.P.
      • Carlstedt-Duke J.
      • Yamamoto K.R.
      • Gustafsson J.-A.
      • Kaptein R.
      ,
      • Luisi B.F.
      • Xu W.X.
      • Otwinowski Z.
      • Freedman L.P.
      • Yamamoto K.R.
      • Sigler P.B.
      ). However, addition of TMAO caused significant changes in the CD spectra, consistent with reduction of random coil conformation and formation of secondary structure with a large contribution of α-helical structure. The absence of an isodichroic point (the single point of intersection of spectra) demonstrates that the conformational transition in TMAO cannot be described in terms of a simple two-state model. The broad peak observed at 218–222 nm in the presence of 2.37 m TMAO may arise from the contribution of conformation other than α-helix (perhaps β-strand). Unfortunately, we cannot estimate the contribution of β-strand conformation in the presence of TMAO by this method, due to high adsorption of the solvent in the far UV region. In the presence of TFE the CD spectra displays clear α-helical character with characteristic maxima at 190 nm and minima at 208 (Fig.3 B). As a first approximation, the conformational transition of GR 1–500 in TFE can be described in terms of a “random coil” to “α-helix” transition with the intersections of six spectra forming an approximate isodichroic point. In contrast to the TMAO-induced transition, which is cooperative, the TFE-induced conformational change is noncooperative (Fig. 3 C), typical for the helix induction curves described for peptides in TFE/H2O mixtures (
      • Luo P.
      • Baldwin R.L.
      ).
      Figure thumbnail gr3
      Figure 3A, CD spectra of GR 1–500 measured in 1.48 m TMAO (dashed line), in 2.37 mTMAO (dotted line), and in the absence of TMAO (solid line). B, CD spectra of GR 1–500 recorded in varied concentrations of TFE (dashed lines, from top tobottom at 222 nm), 10, 20, 30, 40, 50%, and in the absence of TFE (solid line). C, the Q value (× 10−4) at a wavelength of 222 nm plotted as a function of TFE concentration. CD spectra were measured at protein concentration 1.02 μm (55 μg/ml) in 10 mm Tris, 10 mm NaCl, pH 7.9 at 22 °C.

      TFE and TMAO Induce Similar Conformational Change in the Isolated AF1

      When the AF1, which lacks DBD, was expressed, both solutes, TFE and TMAO, induce similar CD changes (Fig.4). With this peptide, addition of either TFE or TMAO decreases the amount of random coil character while promoting formation of α-helical structure. The only data suggesting that the TMAO-induced structure differs from the TFE-induced structure is that the two solvents produce different isodichroic points (202 nm in TFE and >205 nm in TMAO, Fig. 4). If we assume that both solutes induce only α-helical structure in hGR AAD, the efficacy of α-helix formation by TMAO and TFE is approximately equal (compare spectrum obtained in 3 m TMAO with spectrum measured in 20% TFE (2.8 m TFE)). Comparison of the differing CD spectra obtained with GR 1–500 and the AF1 in the presence of TMAO (Fig.3 A and Fig. 4) suggests that the DBD and/or regions adjacent to AF1 may be important for the conformational transition of AF1.
      Figure thumbnail gr4
      Figure 4CD spectra of hGR AF1 (amino acids 77–262) measured in 1, 2, and 3 m TMAO (dotted lines, from top to bottomat 222 nm), in 20, 40, and 60% TFE (dashed lines, from top to bottomat 222 nm), and in the absence of solutes (solid line). CD spectra were measured at protein concentration 8.0 μm (160 μg/ml) in 10 mmTris, 10 mm NaCl, pH 7.9 at 22 °C.

      DISCUSSION

      Our fluorescence and CD data support the earlier observation that the transactivation domain AF1 of the hGR is largely unstructured (
      • Dahlman-Wright K.
      • Baumann H.
      • McEwan I.J.
      • Almlof T.
      • Wright A.P.H.
      • Gustafsson J.-A.
      • Hard T.
      ). Because the hGR with AF1 deleted has only 25–30% transactivation activity of the holo-hGR, the AF1 region is clearly important for determination of the level of transcription of genes that are under glucocorticoid regulation (
      • Almlof T.
      • Wright A.P.H.
      • Gustafsson J.-A.
      ). The AF1 of the hGR is a member of a large family of activation domains (AAD) defined by their richness in acidic residues and little sequence similarity (). Since many such domains are rich in acidic amino acids, previous work led to the idea that acidic residues are crucial for the function of AADs (
      • Mitchell P.J.
      • Tjian R.
      ). According to the “acidic blob” concept (
      • Sigler P.B.
      ), AADs do not adopt a defined structure in vivo, rather it functions by general ionic interactions with target proteins. However, mutagenesis studies of hGR AF1 demonstrate that acidity is not the most important determinant of activity, and negative charges per se are not sufficient for activation (
      • Almlof T.
      • Wright A.P.H.
      • Gustafsson J.-A.
      ,
      • Mason S.A.
      • Housley P.R.
      ). Rather, key hydrophobic amino acids appear to be crucial for activity (
      • Almlof T.
      • Gustafsson J.-A.
      • Wright A.P.H.
      ). That the hGR AF1 might be structured in vivo is suggested by the pattern of AF1 degradation in cell-free extracts, which show defined degradation products that are inconsistent with the indiscriminate proteolysis expected for an unfolded peptide (
      • Almlof T.
      • Wright A.P.H.
      • Gustafsson J.-A.
      ). Structural studies have shown that AADs have the propensity to form α-helical structure in the presence of alcohols, and several proline substitution mutants reduce both helix-forming potential and transactivation activity (
      • Dahlman-Wright K.
      • Baumann H.
      • McEwan I.J.
      • Almlof T.
      • Wright A.P.H.
      • Gustafsson J.-A.
      • Hard T.
      ,
      • Schmitz M.L.
      • Silva M.A.S.
      • Altmann H.
      • Czisch M.
      • Holak T.A.
      • Baeuerle P.A.
      ,
      • Donaldson L.
      • Capone J.P.
      ). Keeping in mind the ability of AADs to form α-helix in the presence of alcohols, one could hypothesize that acidic activation domains are unstructured in vivo until they adopt a more ordered conformation when directly involved in transcriptional activation, according to the induced-fit model of folding (
      • Frankel A.D.
      • Kim P.S.
      ).
      The major concern over using alcohols (TFE, chloroethanol) to probe secondary structures of peptides and proteins is the question of the relevance of alcohol-induced structure to the biologically important conformations of the proteins. These alcohols are such potent inducers of α-helices that helices are forced to occur in peptides/proteins, whereas such structures may be unlikely to exist in vivo(
      • Buck M.
      • Schwalbe H.
      • Dobson C.M.
      ,
      • Fan P.
      • Bracken C.
      • Baum J.
      ,
      • Sönnichsen F.D.
      • Van Eyk J.E.
      • Hodges R.S.
      • Sykes B.D.
      ). As an example, the work of Hoy et al. (
      • Hoy M.V.
      • Leuther K.K.
      • Kodadek T.
      • Johnston S.A.
      ) with AADs from yeast GAL4 and GCN4 transcription factors demonstrated the ability of AADs to adopt a β-sheet conformation under slightly acidic pH condition, a conformation that is biologically important for interaction with target molecules (
      • Leuther K.K.
      • Salmeron J.M.
      • Johnston S.A.
      ). TFE, on the other hand, induces only α-helical conformation in AADs of GAL4 and GCN4 (
      • Hoy M.V.
      • Leuther K.K.
      • Kodadek T.
      • Johnston S.A.
      ). This result emphasizes the importance of the question about the applicability of TFE in probing biologically relevant structures and illustrates the intrinsic plasticity of the transactivation region,i.e. the ability to adopt different conformations depending upon solution conditions.
      Our work shows that: 1) the naturally occurring solute TMAO induces compact structure in the GR 1–500 as indicated by the substantial enhancement in intrinsic fluorescence and blue shift of fluorescent maxima; 2) according to the CD data this structure is different from the α-helix-rich conformation driven by TFE; and 3) TMAO causes the conformational transition to occur as a cooperative event, a process characteristic of proteins with unique structures. Because osmolyte-driven stabilization is a natural process (
      • Yancey P.H.
      • Clark M.E.
      • Hand S.C.
      • Bowlus R.D.
      • Somero G.N.
      ), it is likely that TMAO-induced protein folding can provide a reasonable means of evaluating biologically relevant structures of proteins like hGR.
      It has long been known that TFE increases the propensity of amino acids to form an α-helix, presumably by strengthening the peptide hydrogen bond in TFE/H2O mixtures and through favorable interactions of hydrophobic amino acid side chains with TFE (
      • Luo P.
      • Baldwin R.L.
      ,
      • Cammers-Goodwin A.
      • Allen T.J.
      • Oslick S.L.
      • McClure K.F.
      • Lee J.H.
      • Kemp D.S.
      ). The peptide hydrogen bonds in the helix are believed to be stabilized indirectly by weakening the hydrogen bonding of water molecules to the peptide backbone in the coil form (
      • Cammers-Goodwin A.
      • Allen T.J.
      • Oslick S.L.
      • McClure K.F.
      • Lee J.H.
      • Kemp D.S.
      ). As a result of weakening the hydrophobic interactions within the protein interior, TFE denatures native proteins and promotes helical structure in most peptides and proteins, even though this is nonnative helical structure (
      • Buck M.
      • Schwalbe H.
      • Dobson C.M.
      ,
      • Fan P.
      • Bracken C.
      • Baum J.
      ,
      • Sönnichsen F.D.
      • Van Eyk J.E.
      • Hodges R.S.
      • Sykes B.D.
      ,
      • Luo P.
      • Baldwin R.L.
      ). In contrast, TMAO increases the driving forces for protein folding. We recently found that osmolytes use a new molecular force for protein folding originating from the unfavorable interaction of the TMAO with the peptide backbone (
      • Wang A.
      • Bolen D.W.
      ). Due to its solvophobic effect on the backbone, TMAO forces thermodynamically unstable proteins to fold without altering the rules for folding to a native-like conformation (
      • Baskakov I.V.
      • Bolen D.W.
      ).
      The action of both solutes, TMAO and TFE, focus on the peptide backbone, and this ensures that the effect of both solutes are general in scope, because the backbone is the most prevalent structural element of the protein fabric. In opposition to TFE solution, the propensities of hydrophobic groups to interact with solvent are essentially the same in water as they are in TMAO solution (
      • Wang A.
      • Bolen D.W.
      ). Thus, due to weakening the hydrophobic interactions the dominant effect of TFE on protein is denaturation with preferential formation of α-helices as a result of strengthening peptide hydrogen bonds, whereas TMAO forces unfolded proteins to fold by providing an additional force for folding that has no preference for any particular secondary structure. Based on the molecular origin of TMAO-driven protein folding, if biologically relevant structure can be induced into the transactivation region of hGR (or any other intrinsically unstructured AAD) without its target molecule, it is more likely to be induced by solutes (like TMAO) that have been selected in nature for their ability to fold and stabilize proteins than it is by alcohols.

      REFERENCES

        • Weinreb P.H.
        • Zhen W.
        • Poon A.W.
        • Conway K.A.
        • Lansbury P.T.
        Biochemistry. 1996; 35: 13709-13715
        • Hahn S.
        Cell. 1993; 72: 481-483
        • Frankel A.D.
        • Kim P.S.
        Cell. 1991; 65: 717-719
        • Dahlman-Wright K.
        • Baumann H.
        • McEwan I.J.
        • Almlof T.
        • Wright A.P.H.
        • Gustafsson J.-A.
        • Hard T.
        Proc. Natl. Acad. Sci. U. S. A. 1995; 92: 1699-1703
        • Schmitz M.L.
        • Silva M.A.S.
        • Altmann H.
        • Czisch M.
        • Holak T.A.
        • Baeuerle P.A.
        J. Biol. Chem. 1994; 269: 25613-25620
        • Donaldson L.
        • Capone J.P.
        J. Biol. Chem. 1992; 267: 1411-1414
        • Buck M.
        • Schwalbe H.
        • Dobson C.M.
        Biochemistry. 1995; 34: 13219-13232
        • Fan P.
        • Bracken C.
        • Baum J.
        Biochemistry. 1993; 32: 1573-1582
        • Sönnichsen F.D.
        • Van Eyk J.E.
        • Hodges R.S.
        • Sykes B.D.
        Biochemistry. 1992; 31: 8790-8798
        • Baskakov I.V.
        • Bolen D.W.
        J. Biol. Chem. 1998; 273: 4831-4834
        • Beato M.
        Cell. 1989; 56: 335-344
        • Hard T.
        • Kellenbach E.
        • Boelens R.
        • Maler B.A.
        • Dahlman K.
        • Freedman L.P.
        • Carlstedt-Duke J.
        • Yamamoto K.R.
        • Gustafsson J.-A.
        • Kaptein R.
        Science. 1990; 249: 157-160
        • Luisi B.F.
        • Xu W.X.
        • Otwinowski Z.
        • Freedman L.P.
        • Yamamoto K.R.
        • Sigler P.B.
        Nature. 1991; 352: 497-505
        • Wurtz J.-M.
        • Borguet W.
        • Renaud J.-P.
        • Vivat V.
        • Chambon P.
        • Moras D.
        • Gronemeyer H.
        Nat. Struct. Biol. 1993; 3: 87-95
        • Baskakov I.V.
        • Bolen D.W.
        Biophys. J. 1998; 74: 2666-2673
        • Chen H.
        • Srinivasan G.
        • Thompson E.B.
        J. Biol. Chem. 1998; 272: 25873-25880
        • Graham F.L.
        • Van der Eb A.J.
        Virology. 1973; 52: 456-467
        • Srinivasan G.
        • Thompson E.B.
        Mol. Endocrinol. 1990; 4: 209-216
        • Luo P.
        • Baldwin R.L.
        Biochemistry. 1997; 36: 8413-8421
        • Almlof T.
        • Wright A.P.H.
        • Gustafsson J.-A.
        J. Biol. Chem. 1995; 270: 17535-17540
        • Mitchell P.J.
        • Tjian R.
        Science. 1989; 245: 371-378
        • Sigler P.B.
        Nature. 1988; 333: 210-212
        • Mason S.A.
        • Housley P.R.
        J. Biol. Chem. 1993; 268: 21501-21504
        • Almlof T.
        • Gustafsson J.-A.
        • Wright A.P.H.
        Mol. Cell. Biol. 1997; 17: 934-945
        • Hoy M.V.
        • Leuther K.K.
        • Kodadek T.
        • Johnston S.A.
        Cell. 1993; 72: 587-594
        • Leuther K.K.
        • Salmeron J.M.
        • Johnston S.A.
        Cell. 1993; 72: 575-585
        • Yancey P.H.
        • Clark M.E.
        • Hand S.C.
        • Bowlus R.D.
        • Somero G.N.
        Science. 1982; 217: 1214-1222
        • Cammers-Goodwin A.
        • Allen T.J.
        • Oslick S.L.
        • McClure K.F.
        • Lee J.H.
        • Kemp D.S.
        J. Am. Chem. Soc. 1996; 118: 3082-3090
        • Luo P.
        • Baldwin R.L.
        J. Mol. Biol. 1998; 279: 49-57
        • Wang A.
        • Bolen D.W.
        Biochemistry. 1997; 36: 9101-9108
        • Santoro M.M.
        • Bolen D.W.
        Biochemistry. 1988; 27: 8063-8068